Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections
Main Authors: | Al-Nakeeb, Sadiq, Clermont, Gilles |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2005
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175880/ |
Similar Items
-
Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections
by: Drozdov, Daniel, et al.
Published: (2013) -
Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
by: David T. Huang, et al.
Published: (2017-08-01) -
Can Procalcitonin Reduce Unnecessary Voiding Cystoureterography in Children with First Febrile Urinary Tract Infection?
by: Halimi-asl, Aliasghar, et al.
Published: (2014) -
Prognostic value of procalcitonin in hospitalized patients with lower
respiratory tract infections
by: Nobre, Vandack, et al.
Published: (2016) -
Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial
by: Schuetz, Philipp, et al.
Published: (2007)